Skip to main content

Table 2 Clinical and mycological evaluation of the antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

From: Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis

Control group versus treatment group

Rat/number

FG scoring

Liver

Spleen

Kidneys

Control

1

1

0

1

2

1

1

1

3

1

0

1

4

1

1

0

5

1

1

0

6

1

0

0

PO

1

0

1

0

2

0

1

0

3

0

0

0

4

1

0

0

5

1

0

0

6

1

0

0

AMB

1

0

0

0

2

1

0

0

3

0

0

0

4

1

1

0

5

0

0

0

6

1

0

0

  1. PO piroctone olamine, AMB amphotericin B, FG fungal growth in culture media: (0) no fungal growth and (1) fungal growth